Transcranial magnetic stimulation for treatment of attention in ADHD
Summary
The aim of this study is to see if a 4 week treatment course of brain stimulation (transcranial magnetic stimulation; TMS) can improve attention and behaviour in children with attention deficit/hyperactivity disorder (ADHD).
ADHD can have many symptoms with attention being a common problem. Stimulant treatment can improve attention in many children, but some only have partial improvement and others can't tolerate medications. A promising and alternative option for reducing ADHD symptoms is non-invasive brain stimulation. Transcranial magnetic stimulation (TMS) is a form of non-invasive brain stimulation that involves the application of a magnetic field to the skull to change the behaviour and function of underlying brain areas.
Eligibility
Eligible ages: 9 to 15
Inclusion criteria:
Inclusion Criteria:
(1) Diagnosis of ADHD.
(2) 9-15 years old;
(3) English fluency (to enable consent);
(4) Either taking no medication or taking one stimulant medication with no changes for past 3 months.
(5) Ongoing symptoms of ADHD.
Exclusion criteria:
Exclusion Criteria:
(1) Severe mental health conditions, neurologic illness or injury such as epilepsy or autism.
(2) Impediments to TMS or MRI (such as metal implants in body);
(3) Prior electroconvulsive therapy or vagus nerve stimulation.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Contact research team at Brainkids@ucalgary.ca
Principal investigator:
Kara Murias
Clinical trial:
Yes
REB-ID:
REB20-1415
External links